Drug Resistance
New drug resistance research from University of Bonn, Department of Neuropathology described
Published in Telemedicine Business Week, August 29th, 2007
New research, "Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis," is the subject of a report. According to recent research from Bonn, Germany, "Resistance to chemotherapy is a major complication during treatment of cancer patients. Hypermethylation of the MGMT gene alters DNA repair and is associated with longer survival of glioblastoma patients treated with alkylating agents."
"Therefore, MGMT promoter methylation plays an important role as a predictive biomarker for chemotherapy resistance. To adopt this established correlation into a molecular diagnosis procedure, we compared and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
More Articles from Telemedicine Business Week
- Abdominal Aortic Aneurysm Epidemiology
Researchers at Cornell University have published new data on abdominal aortic aneurysm epidemiology - Abdominal Pain
Research findings from Sungkyunkwan University, Department of Internal Medicine update understanding of abdominal pain - Acidosis Immunology
Recent findings in acidosis immunology described by researchers from Harvard University - Acute Cholecystitis Pathology
Research reports from M. Blaivas and co-authors provide new insights into acute cholecystitis pathology - Acute Diverticulitis
Findings in acute diverticulitis reported from E. Chouillard and co-researchers - Adenomatous Polyp Epidemiology
Study results from M. Picasso and colleagues broaden understanding of adenomatous polyp epidemiology - More from this issue of Telemedicine Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
